Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance T... by Sibylle H. Lob, Mark A. Estabrook, C. Andrew DeRyke, Irina Alekseeva, Fakhar Siddiqui, Katherine Young, Mary R. Motyl, Daniel F. Sahm

Get full text

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020 by James A. Karlowsky, Sibylle H. Lob, Fakhar Siddiqui, Jacqueline Pavia, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Daniel F. Sahm

Get full text

In vitro activity of ceftolozane/tazobactam against Gram‐negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries—SMART 2017–2... by Sibylle H. Lob, Krystyna M. Kazmierczak, Wei-Ting Chen, Fakhar Siddiqui, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Daniel F. Sahm

Get full text

RESISTÊNCIA CRUZADA ANTIMICROBIANA ENTRE ISOLADOS CLÍNICOS DE PSEUDOMONAS AERUGINOSA RECUPERADOS DE TRATO RESPIRATÓRIO INFERIOR - SMART BRASIL 2018-2021 by Amanda Azevedo Bittencourt, Gustavo Mizuno, Marina Della Negra de Paula, Charles Andrew DeRyke, Fakhar Siddiqui, Vinicius Lima Faustino, Paula de Mendonça Batista, Thales José Bueno Polis

Get full text

Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan—SMART 2012–2021... by James A. Karlowsky, Mark G. Wise, Tai-Chin Hsieh, Hung-Chi Lu, Wei-Ting Chen, Ming-Huei Cheng, Fakhar Siddiqui, Katherine Young, Mary R. Motyl, Daniel F. Sahm

Get full text